Holen Sie sich die Stockscreener-App
20.61
0.29%
0.06
Handel nachbörslich:
20.61
Schlusskurs vom Vortag:
$20.55
Offen:
$20.75
24-Stunden-Volumen:
371.21K
Relative Volume:
0.80
Marktkapitalisierung:
$1.22B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-85.21M
KGV:
-10.90
EPS:
-1.89
Netto-Cashflow:
$-68.53M
1W Leistung:
-3.74%
1M Leistung:
+7.34%
6M Leistung:
+12.62%
1J Leistung:
-28.88%
1-Tages-Spanne:
$20.32
$20.82
1-Wochen-Bereich:
$20.10
$22.36
52-Wochen-Spanne:
$13.30
$29.79
Enliven Therapeutics Inc Stock (ELVN) Company Profile
Firmenname
Enliven Therapeutics Inc
Sektor
Branche
Telefon
720-647-8519
Adresse
6200 LOOKOUT ROAD, BOULDER
Vergleichen Sie ELVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELVN
Enliven Therapeutics Inc
|
20.61 | 1.22B | 0 | -85.21M | -68.53M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Eingeleitet | Goldman | Buy |
| 2024-12-13 | Eingeleitet | BTIG Research | Buy |
| 2024-09-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-06-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-09 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Enliven Therapeutics Inc Aktie (ELVN) Neueste Nachrichten
Why Enliven Therapeutics Inc. stock appeals to dividend seekers2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
Real time breakdown of Enliven Therapeutics Inc. stock performanceEntry Point & AI Forecasted Entry/Exit Points - newser.com
Is Enliven Therapeutics Inc. stock a safe haven assetMarket Rally & Community Verified Watchlist Alerts - newser.com
Applying sector rotation models to Enliven Therapeutics Inc.Weekly Loss Report & Free Long-Term Investment Growth Plans - newser.com
Is Enliven Therapeutics Inc. stock cheap compared to fundamentals2025 Market Trends & Low Drawdown Investment Ideas - newser.com
Is Enliven Therapeutics Inc. stock positioned well for digital economyJuly 2025 Volume & AI Optimized Trade Strategies - newser.com
Enliven Therapeutics Inc. recovery potential after sell offQuarterly Trade Summary & Daily Price Action Insights - newser.com
Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Exploring a 100% Upside Potential for Biotech Investors - DirectorsTalk Interviews
Assessing Enliven Therapeutics (ELVN) Valuation as Shares Show Signs of Short-Term Momentum - Yahoo Finance
Enliven Therapeutics Insider Sold Shares Worth $276,025, According to a Recent SEC Filing - MarketScreener
Published on: 2025-10-23 01:40:18 - newser.com
Lyssikatos, chief scientific officer, sells Enliven Therapeutics shares By Investing.com - Investing.com Canada
Brokerages Set Enliven Therapeutics, Inc. (NASDAQ:ELVN) Price Target at $41.20 - Defense World
Enliven Therapeutics CEO Kintz sells $266k in shares By Investing.com - Investing.com UK
ELVN insider sale: 12,500 shares sold; 902,892 shares remain held - Stock Titan
Is now a turning point for Enliven Therapeutics Inc.Global Markets & Risk Controlled Daily Plans - newser.com
Strategies to average down on Enliven Therapeutics Inc.Quarterly Profit Review & AI Powered Market Trend Analysis - newser.com
How to read the order book for Enliven Therapeutics Inc.2025 Institutional Moves & Verified Entry Point Signals - newser.com
Automated trading signals detected on Enliven Therapeutics Inc.Market Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Trading Recap: Why retail investors favor Enliven Therapeutics Inc. stockEarnings Overview Summary & Verified Momentum Stock Watchlist - nchmf.gov.vn
Will Enliven Therapeutics Inc. stock rally after Fed decisions2025 Key Lessons & Real-Time Chart Pattern Alerts - nchmf.gov.vn
Will Enliven Therapeutics Inc. stock split again soon2025 Market WrapUp & Reliable Breakout Forecasts - nchmf.gov.vn
Will Enliven Therapeutics Inc. stock outperform tech sector in 2025July 2025 Institutional & Pattern Based Trade Signal System - nchmf.gov.vn
Heatmap analysis for Enliven Therapeutics Inc. and competitorsWatch List & Target Return Focused Picks - newser.com
Why retail investors favor Enliven Therapeutics Inc. stockWeekly Loss Report & Daily Profit Focused Screening - nchmf.gov.vn
Will Enliven Therapeutics Inc. stock continue dividend increases2025 Performance Recap & Daily Entry Point Trade Alerts - nchmf.gov.vn
(ELVN) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Investor Outlook on a Potential 89.66% Upside - DirectorsTalk Interviews
Finanzdaten der Enliven Therapeutics Inc-Aktie (ELVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):